Ciaramella Giuseppe 4

What Happened

• Giuseppe Ciaramella, President of Beam Therapeutics (BEAM), exercised stock options on June 17, 2026. He acquired 6,505 shares at $0.67 ($4,358) and 29,000 shares at $1.03 ($29,870), for a total of 35,505 shares and $34,228 paid in exercise price.
• The filing shows corresponding derivative interests (the options) were converted/terminated (reported as disposed at $0.00). No sale of the newly acquired shares is reported in the Form 4 excerpt provided.

Key Details

• Transaction date: 2026-06-17.
• Exercise lots: 6,505 shares @ $0.67 = $4,358; 29,000 shares @ $1.03 = $29,870; total acquired = 35,505 shares; total paid = $34,228.
• Derivative disposition: same quantities reported as disposed (price $0.00), indicating conversion/settlement of the option instruments.
• Shares owned after the transaction: not specified in the provided filing excerpt.
• Footnote: F1 — these options originally vested 25% on Feb 26, 2019 (first anniversary of vesting start 2/26/2018) with the remainder vesting over 36 substantially equal monthly installments.
• Filing timing: Form filed June 22, 2026 for a 6/17/2026 transaction (filed five days later); check the full Form 4 for any late-filing notice or transaction timeliness code.

Context

• This was an option exercise (transaction code M). Ciaramella paid the exercise price to convert options into common shares; there is no reported immediate sale (no cashless exercise or market sale shown).
• Option exercises are routine for insiders when options vest; they increase insider share ownership but do not by themselves indicate a view on near-term stock performance.